Finally, we collected the IC50 values of 265 small molecule drugs and their corresponding mRNA gene expression from the Cancer Drug Sensitivity Genomics (GDSC) database in 860 cell lines to identify ARNTL2-related antitumor drugs (Supplementary Table 1). This evidence concerns the gene BMAL2 and cancer.